Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracey H Clark

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Bioanalysis|May 23, 2012
Discovery biotherapeutics bioanalysis: challenges and possible solutionsTracey H Clark, Lindsay E King
Current Drug Metabolism|November 11, 2008
Plasma/serum protein binding determinationsMichael J Banker, Tracey H Clark
Journal of Pharmaceutical Sciences|April 25, 2003
Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein bindingMichael J Banker, Tracey H Clark, John A Williams
Neuroreport|May 23, 2014
Serum β-nerve growth factor concentrations in pregnant female, nonpregnant female, and male cynomolgus monkeysHendrik Neubert, Tracey H Clark, Shibing Deng, et al.
Bioanalysis|July 31, 2015
Antibody-drug conjugates nonclinical support: from early to late nonclinical bioanalysis using ligand-binding assaysSeema Kumar, Lindsay E King, Tracey H Clark, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 2010
The application of target information and preclinical pharmacokinetic/pharmacodynamic modeling in predicting clinical doses of a Dickkopf-1 antibody for osteoporosisAlison M Betts, Tracey H Clark, Jianxin Yang, et al.
The AAPS Journal|July 13, 2016
Feasibility of Singlet Analysis for Ligand Binding Assays: a Retrospective Examination of Data Generated Using the Gyrolab PlatformTracey H Clark, Phillip D Yates, Allison Given Chunyk, et al.
Cancer Immunology, Immunotherapy : CII|October 26, 2017
A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in miceTimothy S Fisher, Andrea T Hooper, Justin Lucas, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bioanalysis|May 23, 2012
Discovery biotherapeutics bioanalysis: challenges and possible solutionsTracey H Clark, Lindsay E King
Current Drug Metabolism|November 11, 2008
Plasma/serum protein binding determinationsMichael J Banker, Tracey H Clark
Journal of Pharmaceutical Sciences|April 25, 2003
Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein bindingMichael J Banker, Tracey H Clark, John A Williams
Neuroreport|May 23, 2014
Serum β-nerve growth factor concentrations in pregnant female, nonpregnant female, and male cynomolgus monkeysHendrik Neubert, Tracey H Clark, Shibing Deng, et al.
Bioanalysis|July 31, 2015
Antibody-drug conjugates nonclinical support: from early to late nonclinical bioanalysis using ligand-binding assaysSeema Kumar, Lindsay E King, Tracey H Clark, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 2010
The application of target information and preclinical pharmacokinetic/pharmacodynamic modeling in predicting clinical doses of a Dickkopf-1 antibody for osteoporosisAlison M Betts, Tracey H Clark, Jianxin Yang, et al.
The AAPS Journal|July 13, 2016
Feasibility of Singlet Analysis for Ligand Binding Assays: a Retrospective Examination of Data Generated Using the Gyrolab PlatformTracey H Clark, Phillip D Yates, Allison Given Chunyk, et al.
Cancer Immunology, Immunotherapy : CII|October 26, 2017
A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in miceTimothy S Fisher, Andrea T Hooper, Justin Lucas, et al.
Pageof 1